Brief: Onesource Specialty Pharma Posts Dec-Quarter Consol Loss Of 887 Million Rupees
23/01/2026 15:18
Jan 23 (Reuters) - Onesource Specialty Pharma Ltd ONEO.NS: DEC-QUARTER CONSOL LOSS 887 MILLION RUPEES DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 2.9 BILLION RUPEES Source text: ID:nnAZN4S3U4T Further company coverage: ONEO.NS ((Reutersbriefs@thomsonreuters.com;))
Recent news on Onesource Specialty Pharma
See all newsBrief: Onesource Specialty Pharma Not To Pursue Merger Of Facilities Of Steriscienceat With Co
Brief: Onesource Specialty Pharma March-Quarter Consol Profit 46 Million Rupees
Brief: Onesource Specialty Pharma Says Orbicular Secures Tentative U.S. FDA ANDA Approval For Generic Ozempic
Brief: Onesource Specialty Pharma Says EU-GMP Certification For Unit II Manufacturing Facility Renewed
Brief: Onesource Specialty Says Onesource-Hikma Secures Approval To Commercialise Generic Ozempic In Saudi Arabia